David M. Knott’s Ascendis Pharma A/S ASND Stock Holding History

David M. Knott’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-526	Closed	-$59K	–	94
2020 Q1	$59K	Sell	526 -130	-20%	-$16.9K	0.04%	102
2019 Q4	$91K	Hold	656	–	–	0.04%	98
2019 Q3	$63K	Buy	+656	New	+$73.2K	0.03%	101

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

David M. Knott's ASND Position: Q2 2020 in Review

David M. Knott sold out of Ascendis Pharma A/S (ASND) in Q2 2020, closing a stake of 526 shares — an estimated $59K sold.

David M. Knott first reported a position in ASND in Q3 2019 and held it in 3 quarters. The position peaked at $91K in Q4 2019. 154 funds tracked by Wall St. Rank hold ASND as of Q2 2020.

David M. Knott reported no remaining Ascendis Pharma A/S position as of Q2 2020 after selling out during the quarter.
David M. Knott sold 526 Ascendis Pharma A/S shares in Q2 2020, an estimated $59K.
David M. Knott first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 3 quarters.
David M. Knott's Ascendis Pharma A/S position peaked at $91K in Q4 2019.
154 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2020.

Based on David M. Knott's 13F filing for Q2 2020, filed 12 Aug 2020.